IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v139y2024ics0168851023002488.html
   My bibliography  Save this article

Making recommendations to subsidize new health technologies in Australia: A qualitative study of decision-makers’ perspectives on committee processes

Author

Listed:
  • Sellars, Marcus
  • Carter, Stacy M.
  • Lancsar, Emily
  • Howard, Kirsten
  • Coast, Joanna

Abstract

To explore experiences of, and perspectives on, health technology assessment (HTA) processes used to produce recommendations about subsidizing new medicines, and medical technologies in Australia, from the perspectives of those experienced in these processes.

Suggested Citation

  • Sellars, Marcus & Carter, Stacy M. & Lancsar, Emily & Howard, Kirsten & Coast, Joanna, 2024. "Making recommendations to subsidize new health technologies in Australia: A qualitative study of decision-makers’ perspectives on committee processes," Health Policy, Elsevier, vol. 139(C).
    • Handle: RePEc:eee:hepoli:v:139:y:2024:i:c:s0168851023002488
    DOI: 10.1016/j.healthpol.2023.104963
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851023002488
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2023.104963?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Klingler, Corinna & Shah, Sara M.B. & Barron, Anthony J.G. & Wright, John S.F., 2013. "Regulatory space and the contextual mediation of common functional pressures: Analyzing the factors that led to the German Efficiency Frontier approach," Health Policy, Elsevier, vol. 109(3), pages 270-280.
    2. Drew Carter & Arlene Vogan & Hossein Haji Ali Afzali, 2016. "Governments Need Better Guidance to Maximise Value for Money: The Case of Australia’s Pharmaceutical Benefits Advisory Committee," Applied Health Economics and Health Policy, Springer, vol. 14(4), pages 401-407, August.
    3. Lopes, Edilene & Carter, Drew & Street, Jackie, 2015. "Power relations and contrasting conceptions of evidence in patient-involvement processes used to inform health funding decisions in Australia," Social Science & Medicine, Elsevier, vol. 135(C), pages 84-91.
    4. Gallego, Gisselle & Casey, Robert & Norman, Richard & Goodall, Stephen, 2011. "Introduction and uptake of new medical technologies in the Australian health care system: A qualitative study," Health Policy, Elsevier, vol. 102(2), pages 152-158.
    5. Wranik, Wiesława Dominika & Zielińska, Dorota Anna & Gambold, Liesl & Sevgur, Serperi, 2019. "Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland," Health Policy, Elsevier, vol. 123(2), pages 191-202.
    6. Kyann Zhang;Martina Garau, 2020. "International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making," Contract Research 002271, Office of Health Economics.
    7. Inhyeong Jeon & Eric C. Ryberg & Pedro J. J. Alvarez & Jae-Hong Kim, 2022. "Technology assessment of solar disinfection for drinking water treatment," Nature Sustainability, Nature, vol. 5(9), pages 801-808, September.
    8. Charlton, Victoria, 2022. "The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies," Health Economics, Policy and Law, Cambridge University Press, vol. 17(4), pages 444-470, October.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Steffensen, Mette B. & Matzen, Christina L. & Wadmann, Sarah, 2022. "Patient participation in priority setting: Co-existing participant roles," Social Science & Medicine, Elsevier, vol. 294(C).
    2. Wranik, Wiesława Dominika & Zielińska, Dorota Anna & Gambold, Liesl & Sevgur, Serperi, 2019. "Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland," Health Policy, Elsevier, vol. 123(2), pages 191-202.
    3. Laurent Frossard & Gregory Merlo & Tanya Quincey & Brendan Burkett & Debra Berg, 2017. "Development of a Procedure for the Government Provision of Bone-Anchored Prosthesis Using Osseointegration in Australia," PharmacoEconomics - Open, Springer, vol. 1(4), pages 301-314, December.
    4. Shilpa Surendran & Chuan De Foo & Chen Hee Tam & Elaine Qiao Ying Ho & David Bruce Matchar & Josip Car & Gerald Choon Huat Koh, 2021. "The Missed Opportunity of Patient-Centered Medical Homes to Thrive in an Asian Context," IJERPH, MDPI, vol. 18(4), pages 1-11, February.
    5. repec:bla:glopol:v:8:y:2017:i::p:69-75 is not listed on IDEAS
    6. Bing Wang & Renee Santoreneos & Hossein Afzali & Lynne Giles & Helen Marshall, 2018. "Costs of Invasive Meningococcal Disease: A Global Systematic Review," PharmacoEconomics, Springer, vol. 36(10), pages 1201-1222, October.
    7. Barron, Anthony J.G. & Klinger, Corinna & Shah, Sara Mehmood Birchall & Wright, John S.F., 2015. "A regulatory governance perspective on health technology assessment (HTA) in France: The contextual mediation of common functional pressures," Health Policy, Elsevier, vol. 119(2), pages 137-146.
    8. Hoon Chuah, Fiona Leh & Srivastava, Aastha & Singh, Shweta Rajkumar & Haldane, Victoria & Huat Koh, Gerald Choon & Seng, Chia Kee & McCoy, David & Legido-Quigley, Helena, 2018. "Community participation in general health initiatives in high and upper-middle income countries: A systematic review exploring the nature of participation, use of theories, contextual drivers and powe," Social Science & Medicine, Elsevier, vol. 213(C), pages 106-122.
    9. Francis Shupo & Keith R. Abrams & Zanfina Ademi & Grace Wayi-Wayi & Natasa Zibelnik & Matt Kirchmann & Carolyn Rutherford & Kelly Makarounas-Kirchmann, 2023. "Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease," PharmacoEconomics - Open, Springer, vol. 7(5), pages 777-792, September.
    10. Matthias Benzer, 2020. "NICE and Society: Health Technology Appraisal and the Cultivation of Social Relations," Sociological Research Online, , vol. 25(2), pages 165-183, June.
    11. Grepstad, Mari & Kanavos, Panos, 2015. "A comparative analysis of coverage decisions for outpatient pharmaceuticals: Evidence from Denmark, Norway and Sweden," Health Policy, Elsevier, vol. 119(2), pages 203-211.
    12. Panos Kanavos & Olivier Wouters & John S. F. Wright & Anthony J. G. Barron & Sara M. B. Shah & Corinna Klingler, 2017. "Convergence, Divergence and Hybridity: A Regulatory Governance Perspective on Health Technology Assessment in England and Germany," Global Policy, London School of Economics and Political Science, vol. 8(s2), pages 69-75, March.
    13. Addo, Rebecca & Hall, Jane & Haas, Marion & Goodall, Stephen, 2020. "The knowledge and attitude of Ghanaian decision-makers and researchers towards health technology assessment," Social Science & Medicine, Elsevier, vol. 250(C).
    14. Phoebe Koundouri & Anthony Cox & Arunima Malik & Ben Groom & Brian O'Callaghan & Cameron Hepburn & Catherine Kilelu & Christine Lins & Dale Squires & E. Somanathan & Heba Handoussa & Ian Bateman & Ism, 2023. "The Recovery from the Covid-19 Pandemic as an Opportunity for a Sustainable and Resilient World," DEOS Working Papers 2311, Athens University of Economics and Business.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:139:y:2024:i:c:s0168851023002488. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.